CRSP
CRISPR Therapeutics AGCompany with tickers: CRSP
CIK
1674416
CUSIP
H17182108
Shares Outstanding
96,448,792
Price History
Institutional Holders
Short Volume
Short Interest
Fails to Deliver
Financials
SEC Filings
Earnings Calls
Insider Trades
Congressional Trades
| Line Item | Value | Unit | Period End | Form | Filed |
|---|---|---|---|---|---|
| Revenue | — | ||||
| Revenue (ASC 606) | $1,458,000 | USD | 2026-03-31 | 10-Q | 2026-05-04 |
| Cost of Revenue | — | ||||
| Gross Profit | — | ||||
| Operating Expenses | $131,706,000 | USD | 2026-03-31 | 10-Q | 2026-05-04 |
| Research & Development | $68,574,000 | USD | 2026-03-31 | 10-Q | 2026-05-04 |
| Operating Income | $-130,248,000 | USD | 2026-03-31 | 10-Q | 2026-05-04 |
| Net Income | $-122,931,000 | USD | 2026-03-31 | 10-Q | 2026-05-04 |
| EPS (Basic) | $-1.28 | USD/shares | 2026-03-31 | 10-Q | 2026-05-04 |
| EPS (Diluted) | $-1.28 | USD/shares | 2026-03-31 | 10-Q | 2026-05-04 |